Author:
Aoude Lauren G.,Heitzer Ellen,Johansson Peter,Gartside Michael,Wadt Karin,Pritchard Antonia L.,Palmer Jane M.,Symmons Judith,Gerdes Anne-Marie,Montgomery Grant W.,Martin Nicholas G.,Tomlinson Ian,Kearsey Stephen,Hayward Nicholas K.
Funder
Rio Tinto Ride to Conquer Cancer
National Health and Medical Research Council (AU)
Genomic Medicine and Cancer Themes of the Oxford NIHR Comprehensive Biomedical Research Centre, the Oxford Experimental Cancer Medicine Centre, Cancer Research UK Programme Grant
Wellcome Trust (GB)
Australia and New Zealand Banking Group Limited Trustees PhD scholarship
Medical Research Council (GB)
Cure Cancer Australia Foundation (AU)
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics(clinical),Oncology,Genetics
Reference32 articles.
1. Gruis NA, van der Velden PA, Sandkuijl LA et al (1995) Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10(3):351–353. doi: 10.1038/ng0795-351
2. Hussussian CJ, Struewing JP, Goldstein AM et al (1994) Germline p16 mutations in familial melanoma. Nat Genet 8(1):15–21. doi: 10.1038/ng0994-15
3. MacGeoch C, Bishop JA, Bataille V et al (1994) Genetic heterogeneity in familial malignant melanoma. Hum Mol Genet 3(12):2195–2200
4. Soufir N, Avril MF, Chompret A et al (1998) Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 7(2):209–216
5. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA. http://evs.gs.washington.edu/EVS/ . Accessed 27 Feb 2014, Cited 14 June 2013
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献